LHS.CN - Liberty Health Sciences Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.76
+0.01 (+1.33%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.75
Open0.00
Bid0.75 x 0
Ask0.76 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume1,094,107
Market Cap257.645M
Beta4.62
PE Ratio (TTM)N/A
EPS (TTM)-0.14
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group8 days ago

    Liberty Health Sciences Launches Revolutionary New Website

    TORONTO , Aug. 13, 2018 /CNW/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty"), a leader in providing premium pharmaceutical-grade cannabis to consumers, announced today that it has launched its much anticipated new website. Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities while keeping consumers' well-being at the forefront of what we do. Liberty has an extensive background in highly regulated industries, with expertise a low-cost producer of premium products. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean, and safe pharmaceutical grade cannabis to consumers.

  • PR Newswire8 days ago

    Liberty Health Sciences Launches Revolutionary New Website

    TORONTO, Aug. 13, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty"), a leader in providing premium pharmaceutical-grade cannabis to consumers, announced today that it has launched its much anticipated new website. Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities while keeping consumers' well-being at the forefront of what we do. Liberty has an extensive background in highly regulated industries, with expertise a low-cost producer of premium products. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean, and safe pharmaceutical grade cannabis to consumers.

  • Liberty Health Sciences Doubles Cultivation Capacity With Expansion of Liberty Health Sciences 360º Innovation Campus
    PR Newswire15 days ago

    Liberty Health Sciences Doubles Cultivation Capacity With Expansion of Liberty Health Sciences 360º Innovation Campus

    TORONTO, Aug. 7, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertycec.com ("Liberty" or the "Company"), a provider of high quality pharmaceutical grade cannabis, announced today that it has doubled its cultivation space in Florida with production commencing at its Liberty Health Sciences 360 Innovation Campus (the "360 Campus") in Gainesville in response to the growing demand by Florida patients. The Company received permission to commence production at the 360 Campus while a retrofit of the facilities is being completed. The Company's Chestnut Hill facility continues to operate at full capacity.

  • Liberty Health Sciences Doubles Cultivation Capacity With Expansion of Liberty Health Sciences 360º Innovation Campus
    CNW Group15 days ago

    Liberty Health Sciences Doubles Cultivation Capacity With Expansion of Liberty Health Sciences 360º Innovation Campus

    TORONTO , Aug. 7, 2018 /CNW/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertycec.com ("Liberty" or the "Company"), a provider of high quality pharmaceutical grade cannabis, announced today that it has doubled its cultivation space in Florida with production commencing at its Liberty Health Sciences 360 Innovation Campus (the "360 Campus") in Gainesville in response to the growing demand by Florida patients. The Company received permission to commence production at the 360 Campus while a retrofit of the facilities is being completed. The Company's Chestnut Hill facility continues to operate at full capacity.

  • Liberty Health Sciences is pleased by Aphria's lock-up agreement on divestiture
    CNW Group29 days ago

    Liberty Health Sciences is pleased by Aphria's lock-up agreement on divestiture

    TORONTO , July 23, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") is pleased to announce Aphria Inc. ("Aphria") has entered into an 18 month lock-up or stand-still agreement with the purchasers of Aphria's shares in Liberty. The divestiture of Liberty stock by Aphria was originally announced on February 5, 2018 as part of Aphria's commitment to the Toronto Stock Exchange.

  • Liberty Health Sciences is pleased by Aphria's lock-up agreement on divestiture
    PR Newswire29 days ago

    Liberty Health Sciences is pleased by Aphria's lock-up agreement on divestiture

    TORONTO, July 23, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") is pleased to announce Aphria Inc. ("Aphria") has entered into an 18 month lock-up or stand-still agreement with the purchasers of Aphria's shares in Liberty. The divestiture of Liberty stock by Aphria was originally announced on February 5, 2018 as part of Aphria's commitment to the Toronto Stock Exchange.

  • CNW Group2 months ago

    Liberty Health Sciences Issues Stock Options and Shares

    Liberty Health Sciences Issues Stock Options and Shares

  • Liberty Health Sciences is Honored to Announce Strategic Partnership with the Veterans Cannabis Project
    PR Newswire2 months ago

    Liberty Health Sciences is Honored to Announce Strategic Partnership with the Veterans Cannabis Project

    TORONTO, July 3, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (LHS.CN) (LHSIF) ("Liberty" or the "Company") is honored to announce its partnership with the Veterans Cannabis Project, an association dedicated to improving US military veterans' quality of life through the opportunity of cannabis. To better provide effective treatment options for those who are serving, and have served, our country in the armed forces, Liberty is collaborating with Veterans Cannabis Project to support vital research projects focused on the treatment of service related trauma with cannabis derived products. In an effort to launch this important alliance and demonstrate the Company's commitment to, and admiration for, veterans nationwide, Liberty will offer a 25% discount on all purchases for armed forces personnel.

  • Liberty Health Sciences is Honored to Announce Strategic Partnership with the Veterans Cannabis Project
    CNW Group2 months ago

    Liberty Health Sciences is Honored to Announce Strategic Partnership with the Veterans Cannabis Project

    TORONTO , July 3, 2018 /CNW/ - Liberty Health Sciences Inc. (LHS.CN) (LHSIF) ("Liberty" or the "Company") is honored to announce its partnership with the Veterans Cannabis Project, an association dedicated to improving US military veterans' quality of life through the opportunity of cannabis. To better provide effective treatment options for those who are serving, and have served, our country in the armed forces, Liberty is collaborating with Veterans Cannabis Project to support vital research projects focused on the treatment of service related trauma with cannabis derived products. In an effort to launch this important alliance and demonstrate the Company's commitment to, and admiration for, veterans nationwide, Liberty will offer a 25% discount on all purchases for armed forces personnel.

  • CNW Group2 months ago

    Horizons ETFs Completes Rebalances of its Marijuana-focused ETFs

    Horizons ETFs Completes Rebalances of its Marijuana-focused ETFs

  • CNW Group2 months ago

    Liberty Health Sciences Earns GMP Certification for Greenhouse and Production Facilities

    TORONTO , June 25, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") today announced it has received Good Manufacturing Practice ("GMP") approval from SAI Global for the Company's ­­greenhouse and production facilities in ­­Alachua County, Florida . The GMP certificate was earned in advance of Liberty's July 5 th deadline for its processing facilities, confirming the site's compliance with FDA's food safety and packaging GMPs.

  • PR Newswire2 months ago

    Liberty Health Sciences Earns GMP Certification for Greenhouse and Production Facilities

    TORONTO, June 25, 2018 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") today announced it has received Good Manufacturing Practice ("GMP") approval from SAI Global for the Company's ­­greenhouse and production facilities in ­­Alachua County, Florida. The GMP certificate was earned in advance of Liberty's July 5th deadline for its processing facilities, confirming the site's compliance with FDA's food safety and packaging GMPs.

  • GlobeNewswire2 months ago

    Grit Capital launches GritCAMP Immersive Investment Conference in Muskoka July 25-27th 2018

    Grit Updates the Market on Recent Corporate Initiatives & Milestones. TORONTO, June 22, 2018-- GRIT CAPITAL INC. a capital markets advisory firm known for its aggressive“ out of the box” thinking to capture ...

  • Move Over Tech: Marijuana Stocks Are the New Star
    Kiplinger2 months ago

    Move Over Tech: Marijuana Stocks Are the New Star

    Cannabis isn't a mainstream investment, but it's a powder keg of potential

  • CNW Group2 months ago

    Liberty Health Sciences commends Congressional push to let states follow their own cannabis rules

    TORONTO , June 7, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") applauds Senators Elizabeth Warren and Cory Gardner for introducing a bipartisan bill that would lift the Controlled Substance Act's restrictions on cannabis in states that have written their own laws. "This is a game-changer," said Liberty Health Sciences CEO George Scorsis .

  • CNW Group3 months ago

    Liberty Health Sciences opens Port St. Lucie's first medical cannabis dispensary

    TORONTO , May 31, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) (" Liberty " or the "Company") today announced the opening of its Cannabis Education Center ("CEC") in Port St. Lucie, Florida . This is Liberty's fourth CEC to open in the state this year and advances the Company's mission to provide Florida's residents with convenient access to high-quality medical cannabis and patient-focused educational resources.

  • CNW Group3 months ago

    Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts

    TORONTO , May 30, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) (" Liberty " or the "Company") is pleased to announce that it has signed a licensing agreement with Isodiol International Inc. ("Isodiol"), a leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products, to provide a complementary suite of medical cannabis products to patients in Florida and Massachusetts . " Liberty is proud to team up with Isodiol, a company renowned for its ability to process and extract high purity CBD on an industrial scale," said George Scorsis , Director and CEO of Liberty .

  • CNW Group3 months ago

    Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products to Massachusetts

    TORONTO , May 25, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") today announced the expansion of the Company's partnership with Colorado -based MM Technology Holdings, LLC ("Mary's") to be the exclusive provider of the award-winning line of Mary's Medicinals® cannabis products in Massachusetts . Under the agreement, Liberty will produce and distribute Mary's suite of innovative cannabis products, featuring a variety of novel delivery methods, under license in Massachusetts for both medical and recreational users, when permitted.

  • CNW Group3 months ago

    Liberty Health Sciences Teams Up with Solomon Wilcots for AAMPA's Conference on the NFL and Medical Cannabis

    TORONTO , May 18, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") today announced it has teamed up with Emmy Award-winning NFL broadcaster and retired player Solomon Wilcots .  Mr. Wilcots is speaking this afternoon in Miami at the American Medical Marijuana Physicians Association's ("AAMPA") conference on "The NFL and Medical Cannabis". "Education is critical to helping doctors and the patients they treat understand and benefit from medical cannabis," said George Scorsis , Director and CEO of Liberty.

  • CNW Group3 months ago

    Liberty Health Sciences Continues Rollout of its Cannabis Education Centers with new Location in Tampa, Florida

    TORONTO , May 18, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) (" Liberty " or the "Company") today announced the successful opening of its Cannabis Education Center ("CEC") in Tampa, Florida . The Tampa location becomes the third CEC to open in the state as part of the Company's strategy to roll its unique patient-centric dispensaries across Florida .

  • PR Newswire3 months ago

    Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing

    TORONTO, May 15, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") has named seasoned marketing executive Stephanie Kubacki as Vice President of Marketing, effective June 1, 2018. Ms. Kubacki comes to Liberty with and exceptional track record managing and building high-profile brands in the highly regulated beverage industry. "I am incredibly excited to welcome Stephanie to the leadership team where she will play an important role in pursuing our aggressive growth strategy" said George Scorsis, Director and CEO of Liberty.

  • Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing
    CNW Group3 months ago

    Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing

    TORONTO , May 15, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) ("Liberty" or the "Company") has named seasoned marketing executive Stephanie Kubacki as Vice President of Marketing, effective June 1, 2018 . Ms. Kubacki comes to Liberty with and exceptional track record managing and building high-profile brands in the highly regulated beverage industry. "I am incredibly excited to welcome Stephanie to the leadership team where she will play an important role in pursuing our aggressive growth strategy" said George Scorsis , Director and CEO of Liberty.

  • CNW Group3 months ago

    Liberty Health Sciences to Bring Solei Cannabis Brand to Florida and Massachusetts

    TORONTO , May 11, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) (" Liberty " or the "Company") today announced it has signed an amended licensing agreement with Aphria Inc. ("Aphria") to add Solei Sungrown Cannabis ("Solei"), to the Company's growing portfolio of brands. Under the terms of the agreement, Liberty will be able to produce and sell Solei in Florida and Massachusetts , subject to receipt of all required approvals from the Florida Department of Health, Office of Medical Marijuana Use, and from the Commonwealth of Massachusetts , Medical Use of Marijuana Program or the Massachusetts Cannabis Control Commission, if any.

  • CNW Group3 months ago

    Liberty Health Sciences Strengthens Presence in Florida with St. Petersburg Cannabis Education Center

    TORONTO , May 10, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (LHSIF) (" Liberty " or the "Company") today announced the successful opening of its second Florida Cannabis Education Center ("CEC") with a grand opening ceremony set for May 17, 2018 at 5:30 pm EST . The St. Petersburg location is strategically located within a five-mile radius of 90 percent of the city's 257,000 residents. "Liberty Health Sciences is proud to be part of the St. Petersburg community and to fulfill our promise to provide the area with our patient-centric approach to cannabis through unparalleled service and educational resources," said George Scorsis , Director and CEO of Liberty .